Schjerven H, Brandtzaeg P, Johansen F E
Laboratory for Immunohistochemistry and Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet, Norway.
J Immunol. 2000 Oct 1;165(7):3898-906. doi: 10.4049/jimmunol.165.7.3898.
The polymeric IgR (pIgR) mediates transport of dimeric IgA and pentameric IgM across mucosal epithelia, thereby generating secretory Abs. Its expression is up-regulated at the transcriptional level by IL-4 in HT-29 cells. In this study, we demonstrate that IL-4 mediates up-regulation of human pIgR through a 554-bp IL-4-responsive enhancer in intron 1. Mutation of a binding site for STAT-6 within this region abolished IL-4-induced enhancement, while an adjacent putative C/EBP site was dispensable. IL-4 treatment induced binding of STAT6 to the intronic STAT6 site, but cooperation with nearby upstream and downstream DNA elements was required for IL-4 responsiveness. Furthermore, IL-4-mediated increased transcription of the pIgR-derived enhancer, like the endogenous pIgR gene, required de novo protein synthesis. Interestingly, a conditionally active form of STAT6 sufficed to activate a pIgR-derived enhancer in HT-29 cells, but not in Cos-1 cells, suggesting a requirement for cell type-specific factors. Thus, STAT6 activation mediates a delayed transcriptional enhancement of pIgR by induction of a de novo synthesized protein that cooperates with STAT6 itself bound to its cognate DNA element in intron 1. This mechanism may represent a general strategy for how pleiotropic cytokines elicit cell type-specific transcriptional responses.
聚合免疫球蛋白受体(pIgR)介导二聚体IgA和五聚体IgM跨黏膜上皮的转运,从而产生分泌型抗体。在HT-29细胞中,其表达在转录水平上被IL-4上调。在本研究中,我们证明IL-4通过内含子1中一个554 bp的IL-4反应增强子介导人pIgR的上调。该区域内STAT-6结合位点的突变消除了IL-4诱导的增强作用,而相邻的假定C/EBP位点则是可有可无的。IL-4处理诱导STAT6与内含子STAT6位点结合,但与附近上游和下游DNA元件的协同作用是IL-4反应性所必需的。此外,与内源性pIgR基因一样,IL-4介导的pIgR衍生增强子转录增加需要从头合成蛋白质。有趣的是,一种条件性激活形式的STAT6足以激活HT-29细胞中pIgR衍生的增强子,但在Cos-1细胞中则不然,这表明需要细胞类型特异性因子。因此,STAT6激活通过诱导一种从头合成的蛋白质来介导pIgR的延迟转录增强,该蛋白质与结合在其内含子1中同源DNA元件上的STAT6自身协同作用。这种机制可能代表了多效性细胞因子引发细胞类型特异性转录反应的一般策略。